MyoKardia Inc (MYOK)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1000 SIERRA POINT PARKWAY BRISBANE, CA 94005

MyoKardia, Inc. operates as a precision cardiovascular medicine company. The Company develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. MyoKardia conducts its business in the United States.

Data as of 2020-08-09
Market Cap5.481 Billion Shares Outstanding53.003 Million Avg 30-day Volume405.221 Thousand
P/E Ratio Dividend Yield EPS-7.1
Price/Sales Price cash flow ratio179.1 Price free cash flow ratio-18.0
Book Value17.14 Price to Tangible Book6.03 Alpha0.05
Short Interest Ratio % Short Interest to Float R-squared0.093647
BETA2.17536 52-week High/Low126.301 / 42.65 Stddev0.294201
View SEC Filings from MYOK instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 7 3 (0.2%)
13F Filers holding this stock: 191 68 (4.45%)
Aggregate 13F shares on 03/31/2020: 48.115 Million 29.529 Million
Aggregate 13F shares on 12/31/2019: 49.635 Million 30.671 Million
Percent change: -3.06% -3.72%
Funds creating new positions: 37 16
Funds Adding to an existing position: 71 25
Funds closing out their position: 21 9
Funds reducing their position: 61 21
Heat Map Ranking for 03/31/2020 38
Heat Map Ranking for 12/31/2019 13
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MYOK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MYOK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

27 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

22 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SANOFI

  • 10% Owner
520,125 2020-07-28 0

MEEKER DAVID P PRESIDENT AND CEO

  • Officer
  • Director
0 2020-07-20 3

FOX JONATHAN C SEE REMARKS

  • Officer
390,967 2020-07-07 0

GIANAKAKOS ANASTASIOS PRESIDENT AND CEO

  • Officer
  • Director
624,790 2020-07-02 20

WAYNICK DENELLE J GENERAL COUNSEL

  • Officer
0 2020-07-01 2

POPOVITS KIMBERLY J

  • Director
0 2020-06-30 3

CRANSTON MARY B

  • Director
0 2020-06-29 4

PERRY MARK L

  • Director
0 2020-06-18 3

AGARWAL SUNIL

  • Director
0 2020-06-18 3

YARNO WENDY L

  • Director
0 2020-06-18 3

LEVIN MARK J

  • Director
  • 10% Owner
0 2020-06-11 0

STARR KEVIN P

0 2020-06-09 0

BAUER JAKE

0 2020-06-04 8

HOMCY CHARLES J CHAIRMAN OF PHARMACEUTICALS

  • Officer
  • Director
0 2020-06-02 0

TOPOL ERIC

  • Director
91,847 2020-05-22 0

HARRIS TAYLOR C. CHIEF FINANCIAL OFFICER

  • Officer
7,438 2020-04-04 4

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-02-14 3

LADD CYNTHIA J GENERAL COUNSEL

  • Officer
0 2020-02-14 3

FAIREY WILLIAM SEE REMARKS

  • Officer
0 2020-02-14 2

LEE JUNE EVP, CHIEF DEVELOPMENT OFFICER

  • Officer
4,153 2019-09-23 2

LAMBING JOSEPH SEE REMARKS

  • Officer
0 2019-02-08 0

SEMIGRAN MARC CHIEF MEDICAL OFFICER

  • Officer
0 2019-02-08 0

CHAN STEVEN SEE REMARKS

  • Officer
0 2019-01-16 0

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
1,158 2019-01-07 3

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
No longer subject to file 2018-03-07 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
1,102,356 2018-01-03 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
1,496,598 2015-11-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-07-02 S 3,224 $94.22 d 19,122 624,790.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-07-02 S 1,776 $93.55 d 22,346 624,790.00 direct yes

WAYNICK DENELLE J - Officer GENERAL COUNSEL

2020-07-01 A 25,000 a 25,000 0.00 direct

WAYNICK DENELLE J - Officer GENERAL COUNSEL

2020-07-01 A 80,000 a 80,000 0.00 direct

CRANSTON MARY B - Director

2020-06-30 M 21,629 $11.69 a 21,629 0.00 direct

CRANSTON MARY B - Director

2020-06-30 S 21,329 $96.59 d 0 0.00 direct

CRANSTON MARY B - Director

2020-06-30 M 21,629 d 0 0.00 direct

CRANSTON MARY B - Director

2020-06-30 S 300 $97.25 d 21,329 0.00 direct

CRANSTON MARY B - Director

2020-06-29 M 371 d 21,629 0.00 direct

CRANSTON MARY B - Director

2020-06-29 S 371 $98.68 d 0 0.00 direct

CRANSTON MARY B - Director

2020-06-29 M 371 $11.69 a 371 0.00 direct

POPOVITS KIMBERLY J - Director

2020-06-18 A 3,000 a 3,000 0.00 direct

CRANSTON MARY B - Director

2020-06-18 A 1,800 a 1,800 0.00 direct

PERRY MARK L - Director

2020-06-18 A 3,000 a 3,000 0.00 direct

YARNO WENDY L - Director

2020-06-18 A 1,800 a 1,800 0.00 direct

MEEKER DAVID P - Director

2020-06-18 A 3,000 a 3,000 0.00 direct

CRANSTON MARY B - Director

2020-06-18 A 3,000 a 3,000 0.00 direct

AGARWAL SUNIL - Director

2020-06-18 A 1,800 a 1,800 0.00 direct

YARNO WENDY L - Director

2020-06-18 A 3,000 a 3,000 0.00 direct

POPOVITS KIMBERLY J - Director

2020-06-18 A 1,800 a 1,800 0.00 direct

PERRY MARK L - Director

2020-06-18 A 1,800 a 1,800 0.00 direct

AGARWAL SUNIL - Director

2020-06-18 A 3,000 a 3,000 0.00 direct

MEEKER DAVID P - Director

2020-06-18 A 1,800 a 1,800 0.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments